2008
DOI: 10.1038/oby.2007.96
|View full text |Cite
|
Sign up to set email alerts
|

Compliance, Behavior Change, and Weight Loss With Orlistat in an Over‐the‐Counter Setting

Abstract: objective:The study was conducted to provide information on how consumers would use orlistat 60 mg, especially in terms of product dosing, in a setting without physician supervision. Methods and Procedures: A 3-month, open-label, naturalistic study was conducted in an over-the-counter (OTC) setting in 18 pharmacies. Consumers ≥18 years were allowed to purchase orlistat packages containing a bottle of orlistat 60 mg plus educational materials, which provided lifestyle information and tools to encourage successf… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
54
0

Year Published

2011
2011
2024
2024

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 30 publications
(54 citation statements)
references
References 9 publications
0
54
0
Order By: Relevance
“…The magnitude of the effects is similar to those reported previously by others. Schwartz et al in an over the counter minimal intervention study of orlistat (60mg) plus written dietary advice on diet and behaviour change reported subjects lost 4.6 ± 0.7kg (Schwartz et al, 2008). Tiikkainen et al reported that orlistat (120 mg) has a beneficial effect of AT distribution.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…The magnitude of the effects is similar to those reported previously by others. Schwartz et al in an over the counter minimal intervention study of orlistat (60mg) plus written dietary advice on diet and behaviour change reported subjects lost 4.6 ± 0.7kg (Schwartz et al, 2008). Tiikkainen et al reported that orlistat (120 mg) has a beneficial effect of AT distribution.…”
Section: Discussionmentioning
confidence: 99%
“…In 2007, orlistat 60mg (alli®) was approved by the FDA as an over-the-counter weight loss medicine. The ability of orlistat 60 mg to significantly reduce body weight has been well-demonstrated (Brochu et al, 2003;Rössner et al, 2000;Anderson et al, 2006;Anderson et al, 2007;Schwartz et al, 2008).…”
Section: Introductionmentioning
confidence: 99%
“…Over 50% of pharmacists reported no sale in the previous 4 weeks, citing cost as the main barrier to sale. Despite evidence that orlistat is clinically effective and safe to supply through community pharmacy [10][11][12] there has been a continued debate about ensuring life-style modification and the importance of intense patient follow up in conjunction with weight loss medication to achieve sustainable results [13,20,21]. However, pharmacy services in the UK do not cater for a sustained patient review and, although ideally placed to provide advice and medicines management as part of the multidisciplinary primary healthcare team [22], funding for such a service was not factored into the direct patient supply of orlistat.…”
Section: Discussionmentioning
confidence: 98%
“…A 3 month, open label naturalistic study carried out in 18 pharmacies across America researching compliance and behaviour changes in patients purchasing orlistat from pharmacy concluded that orlistat could be used safely and appropriately with high consumer satisfaction [13]. However, this study is limited by its open label design and the small number of pharmacies (n = 18) and patients (n = 237) included.…”
Section: Introductionmentioning
confidence: 90%
“…Orlistat (60 mg) is available in UK pharmacies and so can be purchased OTC from pharmacies. OTC orlistat is promoted as a new weight loss aid, "boosting weight loss by 50%" when added to a reduced calorie, lower-fat diet (18,19).…”
Section: An Otc Drug and Weight Controlmentioning
confidence: 99%